Skip to content

Non-randomised trial, 1998

Is there a brain chemistry abnormality in PMDD?

The study found some differences in brain chemistry related to mood in PMDD, with early-cycle levels predicting worse symptoms later in the cycle. The sample was very small and the clinical meaning is unclear.

Early or limited evidence 16 women with PMDD and 15 control women in follicular phase; 10 women with PMDD in late luteal phase

What they did

Non-randomized study examining alpha 2 adrenergic receptor function in blood samples. 16 women with PMDD and 15 control women were tested during the follicular phase; 10 women with PMDD were tested during the late luteal phase. Researchers measured receptor density, binding properties, and coupling to cellular proteins.

What they found

Women with PMDD had significantly lower antagonist affinity in these receptors. In controls, higher receptor density during the follicular phase was associated with fewer symptoms later. In PMDD patients, higher receptor density during the follicular phase predicted worse symptoms during the luteal phase.

What it means for you

PMDD may involve an abnormality in mood-regulating brain chemistry, with early-cycle receptor levels possibly predicting later-cycle symptoms. The sample is very small (16 PMDD women in one phase), so results need confirmation before drawing firm conclusions.

16

women with PMDD in follicular phase

15

control women

10

women with PMDD in luteal phase

About the study

Original title
Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity
Authors
Gurguis GN, Yonkers KA, Phan SP et al.
Journal
Biological psychiatry
Year
1998
Study design
Non-randomised trial
Participants
16
What was tested
None - biological study

Topics